Skip to content

SWEtick - a Prospective Multicenter Study of Tick-borne Diseases in Sweden

Emerging Tick-borne Diseases in Children and Adults in Sweden (SWEtick): a Prospective Multicenter Study for Improved Patient Management

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06781008
Acronym
SWEtick
Enrollment
600
Registered
2025-01-17
Start date
2023-09-01
Completion date
2035-12-01
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tick-Borne Diseases

Keywords

Clinical, Prospective, Multicenter, Observational, Longitudinal, Cohort

Brief summary

The purpose of the SWEtick project is to increase the knowledge of the various clinical presentations of emerging tick-borne diseases (eTBD), to assess their importance for human health, to develop and validate laboratory methods for diagnosis of eTBD, and to develop recommendations for knowledge-driven management of patients with suspected eTBD within the Swedish healthcare system.

Interventions

None listed

Sponsors

Region Jönköping County
Lead SponsorOTHER_GOV
Region Östergötland
CollaboratorOTHER
Region Kalmar County
CollaboratorUNKNOWN
Region Dalarna
CollaboratorUNKNOWN
FORSS - The Research Council of South-Eastern Sweden
CollaboratorUNKNOWN
ALF Grants, Region Östergötland
CollaboratorUNKNOWN
Linkoeping University
CollaboratorOTHER_GOV
Region of Uppsala
CollaboratorUNKNOWN
Region Örebro County
CollaboratorOTHER
Västra Götalandsregionen
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

in TBD and Non-TBD groups: * Clinical suspicion of tick-borne disease (physician's assessment based on medical history, symptoms, clinical findings and sometimes laboratory results)

Exclusion criteria

* Incapacitated to understand the study information and make decisions (adults and adolescents \>15 years)

Design outcomes

Primary

MeasureTime frameDescription
EuroQoL-5 Dimension Questionnaire (EQ-5D)6 monthsDifference in EQ-5D Health index between study inclusion and at the 6 month-follow-up
Visual Analogue Scale for Health (VAS)6 monthsDifference between the VAS units at study inclusion and at 6 month-follow-up.

Countries

Sweden

Contacts

CONTACTAnna J Henningsson, Senior Associate Professor
anna.jonsson.henningsson@rjl.se46 10 242 12 26
CONTACTJohanna Sjöwall, Associate Professor (docent)
johanna.sjowall@liu.se46 10 104 08 94

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026